Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
1.520
-0.090 (-5.59%)
At close: Sep 11, 2025, 4:00 PM EDT
1.480
-0.040 (-2.63%)
After-hours: Sep 11, 2025, 7:50 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $50.45 million as of September 11, 2025. Its market cap has decreased by -39.65% in one year.
Market Cap
50.45M
Enterprise Value
29.83M
1-Year Change
-39.65%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $50.45M, a decrease of -10.86%. That is a compound annual growth rate of -1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 53.40M | 240.13% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |